Washington Trust’s Organon & Co OGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q2
Sell
-1,129
Closed -$16.8K 563
2025
Q1
$16.8K Sell
1,129
-63
-5% -$969 ﹤0.01% 545
2024
Q4
$17.8K Hold
1,192
﹤0.01% 597
2024
Q3
$22.8K Hold
1,192
﹤0.01% 562
2024
Q2
$24.7K Hold
1,192
﹤0.01% 548
2024
Q1
$22.4K Sell
1,192
-4
-0.3% -$69 ﹤0.01% 563
2023
Q4
$17.2K Sell
1,196
-11
-0.9% -$150 ﹤0.01% 573
2023
Q3
$21K Sell
1,207
-140
-10% -$2.92K ﹤0.01% 531
2023
Q2
$28K Sell
1,347
-200
-13% -$4.35K ﹤0.01% 504
2023
Q1
$36.4K Sell
1,547
-12
-0.8% -$322 ﹤0.01% 462
2022
Q4
$43.5K Sell
1,559
-28
-2% -$716 ﹤0.01% 421
2022
Q3
$37K Sell
1,587
-33
-2% -$996 ﹤0.01% 440
2022
Q2
$55K Sell
1,620
-77
-5% -$2.7K ﹤0.01% 390
2022
Q1
$60K Buy
1,697
+30
+2% +$1.03K ﹤0.01% 403
2021
Q4
$51K Sell
1,667
-1,205
-42% -$39.2K ﹤0.01% 437
2021
Q3
$94K Buy
2,872
+2,569
+848% +$82.2K ﹤0.01% 410
2021
Q2
$9K Buy
+303
New +$9.97K ﹤0.01% 795

Other funds holding OGN

Washington Trust's OGN Position: Q2 2025 in Review

Washington Trust sold out of Organon & Co (OGN) in Q2 2025, closing a stake of 1,129 shares — an estimated $16.8K sold.

Washington Trust first reported a position in OGN in Q2 2021 and held it in 16 quarters. The position peaked at $94K in Q3 2021. 695 funds tracked by Wall St. Rank hold OGN as of Q2 2025.

  • Washington Trust reported no remaining Organon & Co position as of Q2 2025 after selling out during the quarter.
  • Washington Trust sold 1,129 Organon & Co shares in Q2 2025, an estimated $16.8K.
  • Washington Trust first reported a position in Organon & Co in Q2 2021 and held it in 16 quarters.
  • Washington Trust's Organon & Co position peaked at $94K in Q3 2021.
  • 695 funds tracked by Wall St. Rank held Organon & Co as of Q2 2025.

Based on Washington Trust's 13F filing for Q2 2025, filed 8 Aug 2025.